This filing reports beneficial ownership of Eastern International Ltd. ordinary shares as of December 31, 2025. Eastern Worldwide Logistics Group Inc. beneficially owns 4,266,000 shares, representing 35.5% of the total outstanding shares. Albert Wong beneficially owns 5,266,000 shares, representing 40.5% of the total o...

This filing details the beneficial ownership of Goh Kok Foong in CCH Holdings Ltd as of December 31, 2025. Goh Kok Foong directly holds 9,720,000 ordinary shares, representing 44.28% of the total outstanding shares. The total number of outstanding ordinary shares was 21,950,000 as of the specified date. Goh Kok Foong e...

Cipher Digital Inc. and its subsidiary, Cipher Mining Technologies Inc., have filed a Schedule 13G, reporting beneficial ownership of 806,439,900 Class A ordinary shares of Canaan Inc. This represents approximately 7.7% of the outstanding Class A ordinary shares. The shares are held through two entities: Cipher Black P...

Cipher Digital Inc. and its subsidiary, Cipher Mining Technologies Inc., have filed a Schedule 13G, reporting beneficial ownership of 806,439,900 Class A ordinary shares of Canaan Inc. This represents approximately 7.7% of the outstanding Class A ordinary shares. The shares are held through two entities: Cipher Black P...

This filing details the beneficial ownership of Goh Kok Foong in CCH Holdings Ltd as of December 31, 2025. Goh Kok Foong directly holds 9,720,000 ordinary shares, representing 44.28% of the total outstanding shares. The total number of outstanding ordinary shares was 21,950,000 as of the specified date. Goh Kok Foong e...

Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have collectively reported beneficial ownership of 5.8% of Jasper Therapeutics, Inc.'s common stock. The filing, dated February 24, 2026, indicates that the securities were acquired and are held with...

Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have collectively reported beneficial ownership of 5.8% of Jasper Therapeutics, Inc.'s common stock. The filing, dated February 24, 2026, indicates that the securities were acquired and are held with...

The State of Wisconsin Investment Board (SWIB) has filed a Schedule 13G with the SEC, reporting its beneficial ownership of Templeton Emerging Markets Fund. SWIB now holds 1,006,525 shares, representing 6.73% of the fund's shares. This filing indicates that SWIB acquired these shares in the ordinary course of business ...

Trails Edge Capital Partners, LP, along with its affiliates Trails Edge Biotechnology Master Fund, LP and Ortav Yehudai, have filed a Schedule 13G, reporting beneficial ownership of 126,010 shares of Sensei Biotherapeutics, Inc. common stock. This represents 9.9% of the outstanding shares as of February 18, 2026. The o...

The State of Wisconsin Investment Board (SWIB) has filed a Schedule 13G with the SEC, reporting its beneficial ownership of Templeton Emerging Markets Fund. SWIB now holds 1,006,525 shares, representing 6.73% of the fund's shares. This filing indicates that SWIB acquired these shares in the ordinary course of business ...

Trails Edge Capital Partners, LP, along with its affiliates Trails Edge Biotechnology Master Fund, LP and Ortav Yehudai, have filed a Schedule 13G, reporting beneficial ownership of 126,010 shares of Sensei Biotherapeutics, Inc. common stock. This represents 9.9% of the outstanding shares as of February 18, 2026. The o...

This Schedule 13G filing pertains to United Homes Group, Inc. and reports a beneficial ownership of 7.00% of the Class A Common Shares by Hilary L. Shane Revocable Trust. The trust, represented by Hilary L. Shane, holds 1,529,982 shares. Hilary L. Shane is a US citizen, and the trust was formed in Florida. The filing i...

This Schedule 13G filing pertains to United Homes Group, Inc. and reports a beneficial ownership of 7.00% of the Class A Common Shares by Hilary L. Shane Revocable Trust. The trust, represented by Hilary L. Shane, holds 1,529,982 shares. Hilary L. Shane is a US citizen, and the trust was formed in Florida. The filing i...

RPD Fund Management LLC, along with RPD Opportunity Fund LP, RPD Opportunity LLC, and Ahmet H. Okumus, collectively hold a 9.1% stake in Appian Corporation. This filing indicates a shift in ownership, with RPD Fund Management LLC now holding 3,900,656 shares, representing 9.1% of the company's Class A Common Stock. The...

This filing details the beneficial ownership of Avalo Therapeutics, Inc. common stock by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. As of February 24, 2026, Millennium Management LLC reported beneficial ownership of 934,429 shares, representing 5.0% of the class. This ownership...

Fourth Sail Capital LP, along with Ariel Merenstein, Fourth Sail Capital US LP, Tordesilhas Capital Gestora De Recursos Ltda., and Fourth Sail Long Short LLC, has filed a Schedule 13G indicating beneficial ownership of 6.21% of CALAVO GROWERS INC ordinary shares. The total number of shares beneficially owned is 1,109,3...

Commodore Capital LP, along with its affiliates Commodore Capital Master LP, Michael Kramarz, and Robert Egen Atkinson, has reported acquiring a 9.9% stake in IMMUNIC, INC. (IMUX). The total beneficial ownership amounts to 13,350,121 shares of common stock. This acquisition includes shares underlying pre-funded warrant...

This filing reports that Paradigm BioCapital Advisors LP, along with Paradigm BioCapital Advisors GP LLC, Senai Asefaw, M.D., and Paradigm BioCapital International Fund Ltd., collectively hold a 5.1% stake in EyePoint, Inc. as of February 17, 2026. The total number of shares beneficially owned by Paradigm BioCapital Ad...

Felix Holdings B.V. has acquired a significant stake in TRUPANION, INC., now beneficially owning 4,296,538 shares, representing 9.89% of the company's outstanding common stock. This acquisition occurred on February 17, 2026, with the filing dated February 24, 2026. The shares were not acquired for the purpose of influe...

Fourth Sail Capital LP, along with Ariel Merenstein, Fourth Sail Capital US LP, Tordesilhas Capital Gestora De Recursos Ltda., and Fourth Sail Long Short LLC, has filed a Schedule 13G indicating beneficial ownership of 6.21% of CALAVO GROWERS INC ordinary shares. The total number of shares beneficially owned is 1,109,3...

Trails Edge Capital Partners, LP, along with Trails Edge Biotechnology Master Fund, LP, and Ortav Yehudai, reported beneficial ownership of 11,454,000 shares of Immunic, Inc. common stock as of February 17, 2026. This constitutes 8.7% of the outstanding shares. The ownership is primarily held through pre-funded warrant...

Commodore Capital LP, along with its affiliates Commodore Capital Master LP, Michael Kramarz, and Robert Egen Atkinson, has reported acquiring a 9.9% stake in IMMUNIC, INC. (IMUX). The total beneficial ownership amounts to 13,350,121 shares of common stock. This acquisition includes shares underlying pre-funded warrant...

Integrated Core Strategies (US) LLC, along with Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, has reported a 9.6% ownership of Spruce Biosciences, Inc. common stock. This filing, a Schedule 13G, indicates that as of February 17, 2026, Integrated Core Strategies (US) LLC beneficial...

Springhouse Capital Management, LP, along with its affiliated entities and Brian Gaines, has reported beneficial ownership of 905,874 shares of Lovesac Co. common stock, representing 6.2% of the class. Brian Gaines individually holds 918,674 shares, constituting 6.28% ownership. This filing, dated February 24, 2026, pe...

This filing details the beneficial ownership of Avalo Therapeutics, Inc. common stock by Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. As of February 24, 2026, Millennium Management LLC reported beneficial ownership of 934,429 shares, representing 5.0% of the class. This ownership...